tiprankstipranks
Trending News
More News >
Lifecore Biomedical (LFCR)
NASDAQ:LFCR
US Market
Advertisement

Lifecore Biomedical (LFCR) Ratios

Compare
137 Followers

Lifecore Biomedical Ratios

LFCR's free cash flow for Q3 2025 was $0.28. For the 2025 fiscal year, LFCR's free cash flow was decreased by $ and operating cash flow was $-0.26. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
2.71 2.56 1.56 1.46 0.96
Quick Ratio
1.59 1.39 0.72 0.77 0.55
Cash Ratio
0.17 0.49 0.02 0.01 <0.01
Solvency Ratio
-0.16 -0.36 -0.21 -0.08 -0.06
Operating Cash Flow Ratio
0.10 -0.89 -0.31 0.15 -0.10
Short-Term Operating Cash Flow Coverage
3.45 -59.41 -0.18 0.52 -0.19
Net Current Asset Value
$ -151.25M$ -157.73M$ -63.31M$ -151.82M$ -153.16M
Leverage Ratios
Debt-to-Assets Ratio
0.55 0.44 0.52 0.44 0.41
Debt-to-Equity Ratio
58.48 -61.21 1.42 1.09 0.96
Debt-to-Capital Ratio
0.98 1.02 0.59 0.52 0.49
Long-Term Debt-to-Capital Ratio
0.98 1.02 0.47 0.45 0.30
Financial Leverage Ratio
106.64 -138.52 2.73 2.48 2.34
Debt Service Coverage Ratio
-0.47 -1.93 0.05 0.47 0.06
Interest Coverage Ratio
-0.89 -1.43 0.20 -0.45 -0.86
Debt to Market Cap
0.44 0.43 0.81 0.57 0.60
Interest Debt Per Share
4.12 4.37 5.78 8.08 7.91
Net Debt to EBITDA
-11.37 -2.60 77.11 16.93 -30.83
Profitability Margins
Gross Profit Margin
33.45%26.43%27.21%14.97%12.70%
EBIT Margin
-14.09%-44.81%-2.81%-0.20%-4.40%
EBITDA Margin
-8.43%-34.84%1.06%2.39%-1.21%
Operating Profit Margin
-15.11%-25.26%1.86%-1.26%-1.41%
Pretax Profit Margin
-34.31%-66.53%-27.95%-7.44%-8.69%
Net Profit Margin
-34.27%-98.96%-24.80%-6.00%-6.47%
Continuous Operations Profit Margin
-34.27%-62.20%-8.33%-4.31%-3.70%
Net Income Per EBT
99.89%148.74%88.75%80.72%74.44%
EBT Per EBIT
227.09%263.40%-1501.53%589.63%618.23%
Return on Assets (ROA)
-18.79%-40.05%-15.60%-6.50%-7.06%
Return on Equity (ROE)
-264.05%5547.77%-42.62%-16.11%-16.53%
Return on Capital Employed (ROCE)
-9.53%-12.05%1.60%-1.71%-2.20%
Return on Invested Capital (ROIC)
-9.30%-12.00%0.86%-1.28%-1.31%
Return on Tangible Assets
-20.33%-43.11%-17.32%-8.22%-8.80%
Earnings Yield
-15.68%-42.96%-15.85%-9.58%-12.08%
Efficiency Ratios
Receivables Turnover
6.73 3.56 4.85 13.13 7.75
Payables Turnover
11.71 3.44 10.44 28.39 9.98
Inventory Turnover
2.51 1.67 2.02 6.64 7.77
Fixed Asset Turnover
1.00 0.77 1.34 2.72 2.71
Asset Turnover
0.55 0.40 0.63 1.08 1.09
Working Capital Turnover Ratio
2.61 1.97 4.08 27.80 -104.20
Cash Conversion Cycle
168.68 214.46 221.06 69.89 57.50
Days of Sales Outstanding
54.24 102.58 75.27 27.79 47.12
Days of Inventory Outstanding
145.61 218.03 180.74 54.96 46.96
Days of Payables Outstanding
31.17 106.16 34.96 12.86 36.58
Operating Cycle
199.85 320.61 256.02 82.74 94.08
Cash Flow Ratios
Operating Cash Flow Per Share
0.09 -1.15 -0.83 0.51 -0.58
Free Cash Flow Per Share
-0.29 -1.84 -1.78 -0.30 -1.50
CapEx Per Share
0.38 0.69 0.95 0.81 0.92
Free Cash Flow to Operating Cash Flow
-3.35 1.60 2.15 -0.58 2.57
Dividend Paid and CapEx Coverage Ratio
0.23 -1.66 -0.87 0.63 -0.64
Capital Expenditure Coverage Ratio
0.23 -1.66 -0.87 0.63 -0.64
Operating Cash Flow Coverage Ratio
0.02 -0.31 -0.16 0.07 -0.08
Operating Cash Flow to Sales Ratio
0.02 -0.33 -0.13 0.03 -0.03
Free Cash Flow Yield
-3.77%-23.22%-18.06%-2.57%-13.83%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-6.41 -2.33 -6.31 -10.44 -8.28
Price-to-Sales (P/S) Ratio
2.20 2.30 1.57 0.63 0.54
Price-to-Book (P/B) Ratio
128.47 -129.13 2.69 1.68 1.37
Price-to-Free Cash Flow (P/FCF) Ratio
-26.66 -4.31 -5.54 -38.96 -7.23
Price-to-Operating Cash Flow Ratio
89.18 -6.90 -11.92 22.71 -18.55
Price-to-Earnings Growth (PEG) Ratio
0.03 -0.02 -0.16 0.72 <0.01
Price-to-Fair Value
128.47 -129.13 2.69 1.68 1.37
Enterprise Value Multiple
-37.44 -9.21 225.19 43.15 -74.97
Enterprise Value
409.65M 331.52M 442.28M 561.09M 536.87M
EV to EBITDA
-37.29 -9.21 225.19 43.15 -74.97
EV to Sales
3.14 3.21 2.38 1.03 0.91
EV to Free Cash Flow
-38.13 -6.00 -8.42 -64.11 -12.28
EV to Operating Cash Flow
127.58 -9.62 -18.13 37.36 -31.50
Tangible Book Value Per Share
-0.43 -0.67 2.67 3.32 4.24
Shareholders’ Equity Per Share
0.06 -0.06 3.67 6.92 7.92
Tax and Other Ratios
Effective Tax Rate
<0.01 >-0.01 0.11 0.19 0.26
Revenue Per Share
3.52 3.45 6.31 18.58 20.24
Net Income Per Share
-1.21 -3.41 -1.56 -1.12 -1.31
Tax Burden
1.00 1.49 0.89 0.81 0.74
Interest Burden
2.43 1.48 9.95 37.30 1.97
Research & Development to Revenue
0.06 0.08 0.04 0.02 0.02
SG&A to Revenue
0.00 0.42 0.23 0.12 0.12
Stock-Based Compensation to Revenue
0.08 <0.01 <0.01 <0.01 <0.01
Income Quality
-0.07 0.34 0.25 -0.46 0.45
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis